Key result
Advanced rheumatoid arthritis therapies dramatically improve clinical outcomes and enable remission despite ongoing cost challenges.
Why the study?
Advances in therapy for rheumatoid arthritis have improved clinical outcomes and remission rates, but challenges remain in diagnosis, treatment, and cost-effective care.
Advances in therapy have improved clinical outcomes and made remission possible for many patients with rheumatoid arthritis.
Rheumatoid arthritis is the most common form of inflammatory arthritis. Because of advances in therapy, clinical outcomes have improved dramatically and remission is possible for many patients. These advances have come with many challenges, prompting consideration of strategies to improve diagnosis and treatment and implement more cost-effective care.
No takes yet. Share an insight, caveat, or question.
David S. Pisetsky (2017) studied this question. Advances in rheumatoid arthritis therapy have dramatically improved clinical outcomes and made remission possible for many patients, despite ongoing challenges in implementing cost-effective care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: